NCT Number: NCT01854879
Evaluation of Nucleus 6 Sound Coding Algorithms
The purpose of the study was to evaluate the features of the Nucleus 6 Sound Processor (CP900 series) on existing Nucleus recipients who currently use the previous generation sound processor, the Cochlear Nucleus CP810 (also commonly known as the Nucleus 5), with a Cochlear Nucleus CI24RE, CI512 or CI422 cochlear implant. The features evaluated included an enhanced Automatic Gain Control (eAGC), the option to provide acoustic amplification in combination with traditional electric stimulation through an acoustic component, and three input processing algorithms: Signal to Noise Ratio - Noise Canceller (SNR-NC), Wind Noise Reduction (WNR) and Automatic Scene Analyzer (SCAN).
As is customary for a single-subject research design, study results will be analyzed for each subject individually. For evaluations where testing took place under two conditions (i.e. Endpoint 2, 3, 4, and 5) a non-inferiority hypothesis test based on the paired comparisons of the % of words correct will be performed. For each subject, the paired difference (P1 minus P2) will be calculated and the mean difference will be tested statistically against a non-inferiority null hypothesis of 10%. Successful rejection of the null hypothesis allows for a conclusion that the performance under the test condition 2 (based on the Nucleus 6 sound processor) will be non-inferior to the test condition 1 (based on the Nucleus 5 sound processor).
Ho: P1 - P2 ≥ 10% Ha: P1 - P2 < 10%
We hypothesize acceptance of the null hypothesis for the Nucleus 6 features.
Testing will be based on a paired t-test with a one-sided 0.05 alpha level. The value of 10% was selected as the non-inferiority margin as one that can be tested with reasonable power and was clinically meaningful.
Looking for future studies?
Notify MeKey information
Conditions
Age range
8 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Eight years of age or older
- CI24RE, CI500 or CI422 series Nucleus cochlear implant types (commercially approved)
- At least 3 months experience with the cochlear implant
- Post-linguistic onset of bilateral sensorineural hearing loss, with no congenital component to the hearing loss
- Native speaker of English, the language used to assess speech perception performance
- Willingness to participate in and to comply with all requirements of the protocol
Exclusion criteria
- Unrealistic expectations on the part of the subject, regarding the possible benefits, risks, and limitations that are inherent to the prosthetic device 2. Unwillingness or inability of the candidate to comply with all investigational requirements 3. Additional handicaps that would prevent or restrict participation in the audiological evaluations
-
Treatment and study plan
Primary outcomes
-
Percentage of Words Correct on AzBio Sentences in Noise S0N90
Time frame: Each assessment was completed acutely which equated to approximately 2 hours of testing
Individuals were tested with AzBio Sentences in Noise using a speech front (0 degrees) and noise presented to the implant ear (90 degrees) using the following features: enhanced Automatic Gain Control (eAGC), Signal to Noise Ratio - Noise Canceller (SNR-NC), Wind Noise Reduction (WNR) and Automatic Scene Analyzer (SCAN).
Sponsors and collaborators
Lead sponsor
Cochlear
Industry
Registry information
Important dates
- Study start
- 2013
- Primary completion
- 2013
- Study completion
- 2013
- First posted
- May 16, 2013
- Registry last updated
- Nov 23, 2020
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
A Computational Approach to Optimal Deactivation of Cochlear Implant Electrodes
NCT05219474
Ear Diseases, Hearing Disorders
New York, United States
View Trial DetailsElectrophysiological Study of Interindividual Differences in Speech-understanding Among Cochlear Implant Patients
NCT01805167
Ear Diseases, Hearing Disorders
Nice, France
View Trial DetailsACHIEVE Hearing Intervention Follow-Up Study
NCT05070429
Aging, Ear Diseases
Hagerstown, Maryland, United States
View Trial DetailsRemote Microphone Performance Comparison in Adults With Hearing Loss
NCT07501312
Ear Diseases, Hearing Disorders
Aurora, Illinois, United States
View Trial Details